Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Deciphera Pharmaceuticals (DCPH)

Deciphera Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DCPH
DateTimeSourceHeadlineSymbolCompany
14/06/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:DCPHDeciphera Pharmaceuticals Inc
12/06/202401:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DCPHDeciphera Pharmaceuticals Inc
12/06/202401:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DCPHDeciphera Pharmaceuticals Inc
12/06/202401:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DCPHDeciphera Pharmaceuticals Inc
12/06/202401:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DCPHDeciphera Pharmaceuticals Inc
12/06/202401:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DCPHDeciphera Pharmaceuticals Inc
12/06/202401:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DCPHDeciphera Pharmaceuticals Inc
12/06/202401:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DCPHDeciphera Pharmaceuticals Inc
12/06/202401:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DCPHDeciphera Pharmaceuticals Inc
11/06/202422:18Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:DCPHDeciphera Pharmaceuticals Inc
11/06/202422:16Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:DCPHDeciphera Pharmaceuticals Inc
11/06/202422:14Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:DCPHDeciphera Pharmaceuticals Inc
11/06/202422:12Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:DCPHDeciphera Pharmaceuticals Inc
11/06/202422:10Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:DCPHDeciphera Pharmaceuticals Inc
11/06/202422:08Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:DCPHDeciphera Pharmaceuticals Inc
11/06/202422:06Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:DCPHDeciphera Pharmaceuticals Inc
11/06/202422:04Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:DCPHDeciphera Pharmaceuticals Inc
11/06/202422:02Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:DCPHDeciphera Pharmaceuticals Inc
11/06/202422:01Edgar (US Regulatory)Form POSASR - Post-effective Amendment to an automatic shelf registration statementNASDAQ:DCPHDeciphera Pharmaceuticals Inc
11/06/202414:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DCPHDeciphera Pharmaceuticals Inc
11/06/202414:18Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:DCPHDeciphera Pharmaceuticals Inc
11/06/202414:15Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:DCPHDeciphera Pharmaceuticals Inc
03/06/202412:00Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:DCPHDeciphera Pharmaceuticals Inc
03/06/202412:00Business WireDeciphera Pharmaceuticals Announces Oral Presentation of Results from MOTION Pivotal Phase 3 Study of Vimseltinib in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the 2024 ASCO Annual Meeting and Online Publication in The LancetNASDAQ:DCPHDeciphera Pharmaceuticals Inc
28/05/202411:08Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:DCPHDeciphera Pharmaceuticals Inc
22/05/202414:06Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:DCPHDeciphera Pharmaceuticals Inc
22/05/202412:01Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:DCPHDeciphera Pharmaceuticals Inc
13/05/202411:32Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:DCPHDeciphera Pharmaceuticals Inc
13/05/202411:31Edgar (US Regulatory)Form SC TO-T - Tender offer statement by Third PartyNASDAQ:DCPHDeciphera Pharmaceuticals Inc
10/05/202412:27Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DCPHDeciphera Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:DCPH